Ulloa L, Doody J, Massagué J
Cell Biology Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Nature. 1999 Feb 25;397(6721):710-3. doi: 10.1038/17826.
Transforming growth factor-beta (TGF-beta) and interferon-gamma (IFN-gamma) have opposite effects on diverse cellular functions, but the basis for this antagonism is not known. TGF-beta signals through a receptor serine kinase that phosphorylates and activates the transcription factors Smads 2 and 3, whereas the IFN-gamma receptor and its associated protein tyrosine kinase Jak1 mediate phosphorylation and activation of the transcription factor Stat1. Here we present a basis for the integration of TGF-beta and IFN-gamma signals. IFN-gamma inhibits the TGF beta-induced phosphorylation of Smad3 and its attendant events, namely, the association of Smad3 with Smad4, the accumulation of Smad3 in the nucleus, and the activation of TGFbeta-responsive genes. Acting through Jak1 and Stat1, IFN-gamma induces the expression of Smad7, an antagonistic SMAD, which prevents the interaction of Smad3 with the TGF-beta receptor. The results indicate a mechanism of transmodulation between the STAT and SMAD signal-transduction pathways.
转化生长因子-β(TGF-β)和干扰素-γ(IFN-γ)对多种细胞功能具有相反的作用,但其拮抗作用的基础尚不清楚。TGF-β通过一种受体丝氨酸激酶发出信号,该激酶磷酸化并激活转录因子Smad2和Smad3,而IFN-γ受体及其相关的蛋白酪氨酸激酶Jak1介导转录因子Stat1的磷酸化和激活。在此,我们提出了TGF-β和IFN-γ信号整合的基础。IFN-γ抑制TGF-β诱导的Smad3磷酸化及其伴随事件,即Smad3与Smad4的结合、Smad3在细胞核中的积累以及TGF-β反应性基因的激活。通过Jak1和Stat1起作用,IFN-γ诱导拮抗型SMAD蛋白Smad7的表达,从而阻止Smad3与TGF-β受体的相互作用。这些结果表明了STAT和SMAD信号转导途径之间的转调节机制。